10-Q 1 f10q0319_metaurusequity.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2019

 

OR

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                     

 

Commission File Number: 333-221591

 

METAURUS EQUITY COMPONENT TRUST

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   35-2594229
30-0987130
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
c/o Metaurus Advisors LLC
589 Fifth Avenue, Suite 808
New York, New York
  10017
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 634-4250

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes      No  

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Small reporting company
    Emerging Growth Company

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No  

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Shares of U.S. Equity Cumulative Dividends Fund – Series 2027   IDIV   NYSE Arca, Inc.
Shares of U.S. Equity Ex-Dividend Fund – Series 2027   XDIV   NYSE Arca, Inc.

 

As of April 15, 2019, the Registrant had 600,000 shares outstanding.

 

 

 

 

 

 

Table of Contents

 

    Page
PART I. FINANCIAL INFORMATION  
Item 1. Financial Statements 1
  U.S. Equity Cumulative Dividends Fund—Series 2027  
  Statements of Financial Condition as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 2
  Schedules of Investments as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 3
  Statements of Operations for the Three Months Ended March 31, 2019 and 2018 (unaudited) 5
  Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (unaudited) 6
  Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (unaudited) 7
  U.S. Equity Ex-Dividend Fund—Series 2027  
  Statements of Financial Condition as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 8
  Schedules of Investments as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 9
  Statements of Operations for the Three Months Ended March 31, 2019 and 2018 (unaudited) 11
  Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (unaudited) 12
  Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (unaudited) 13
  Notes to Unaudited Financial Statements 14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 26
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Item 4. Controls and Procedures 27
PART II. OTHER INFORMATION  
Item 1. Legal Proceedings 28
Item 1A. Risk Factors 28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Item 3. Defaults Upon Senior Securities 28
Item 4. Mine Safety Disclosures 28
Item 5. Other Information 28
Item 6. Exhibits 28
Signatures 29
Exhibit Index 30

 

i

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Index

 

Documents

 

Statements of Financial Condition, Schedules of Investments, Statements of Operations, Statements of Changes in Shareholders’ Equity and Statements of Cash Flows:

 

  Page
U.S. Equity Cumulative Dividends Fund—Series 2027  
Statements of Financial Condition as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 2
Schedules of Investments as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 3
Statements of Operations for the Three Months Ended March 31, 2019 and 2018 (unaudited) 5
Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (unaudited) 6
Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (unaudited) 7
   
U.S. Equity Ex-Dividend Fund—Series 2027
Statements of Financial Condition as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 8
Schedules of Investments as of March 31, 2019 (unaudited) and December 31, 2018 (audited) 9
Statements of Operations for the Three Months Ended March 31, 2019 and 2018 (unaudited) 11
Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (unaudited) 12
Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (unaudited) 13

 

1

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Statements of Financial Condition

 

   (Unaudited)   (Audited) 
   March 31,
2019
   December 31,
2018
 
Assets        
Investments,  at Fair Value (Cost  $4,092,613 and $4,453,987, respectively)  $4,178,878   $4,495,280 
Cash and Cash Equivalents   207,337    212,744 
Cash pledged as collateral on Futures Contracts   87,759    70,768 
Interest Receivable   32,881    9,007 
Receivable from Advisor   14,509    15,459 
Variation Margin Receivable   9,188    - 
Deferred Offering Costs   123,902    123,816 
Total Assets  $4,654,454   $4,927,074 
           
Liabilities          
Due to Advisor   124,500    124,500 
Payable to Administrator   -    3,185 
Variation Margin Payable on Open Futures Contracts   6,125    28,500 
Income Distribution Payable   43,750    56,000 
Other Accrued Expenses   234,932    188,029 
Total Liabilities  $409,307   $400,214 
           
Shareholders’ Equity          
Authorized Participants (350,000 Shares and 400,000 Shares Outstanding, respectively)  $4,245,147   $4,526,860 
Net Asset Value Per Share  $12.13   $11.32 
Market Price Per Share  $12.16   $11.33 

 

See accompanying notes to financial statements.

 

2

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Schedule of Investments

March 31, 2019 (Unaudited)

 

Description  Principal Amount   Value 
U.S. TREASURY OBLIGATIONS -  98.5%        
U.S. Treasury Notes        
6.125%, 11/15/2027 (1)  $432,000   $557,626 
2.250%, 12/31/2023 (1)   455,000    455,275 
2.250%, 11/15/2024 (1)   489,000    488,350 
2.250%, 11/15/2025 (1)   497,000    495,078 
2.125%, 12/31/2022 (1)   442,000    440,455 
2.000%, 12/31/2021 (1)   427,000    424,598 
2.000%, 11/15/2026 (1)   518,000    505,839 
1.750%, 12/31/2020 (1)   407,000    403,121 
1.625%, 12/31/2019   411,000    408,536 
           
Total U.S. Treasury Obligations          
(Cost  $4,092,613)        4,178,878 
           
Total Investments - 98.5%          
(Cost  $4,092,613)       $4,178,878 

 

Percentages are based on net assets of $4,244,549.

 

A list of the open futures contracts held by the Fund at March 31, 2019, is as follows:

 

   Number of             Unrealized 
   Contracts  Expiration  Notional       Appreciation 
Type of Contract  Long  Date  Amount   Value   (Depreciation) 
S&P 500 Annl Div  Dec19  35  12/23/2019  $495,117   $502,688   $7,571 
S&P 500 Annl Div  Dec20  35  12/21/2020   517,617    517,562    (55)
S&P 500 Annl Div  Dec21  35  12/20/2021   537,617    525,438    (12,179)
S&P 500 Annl Div  Dec22  35  12/19/2022   554,617    534,188    (20,429)
S&P 500 Annl Div  Dec23  35  12/18/2023   568,679    543,812    (24,867)
S&P 500 Annl Div  Dec24  35  12/23/2024   584,929    559,125    (25,804)
S&P 500 Annl Div  Dec25  35  12/22/2025   599,554    568,750    (30,804)
S&P 500 Annl Div  Dec26  35  12/21/2026   614,492    577,937    (36,555)
S&P 500 Annl Div  Dec27  35  12/20/2027   629,555    586,688    (42,867)
Net Unrealized Appreciation (Depreciation)                  $(185,989)

 

(1)Security, or a portion of these securities, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended March 31, 2019 was $519,483 or 12.2 % of net assets.

 

See accompanying notes to financial statements.

 

3

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Schedule of Investments

December 31, 2018 (Audited)

 

Description  Principal Amount   Value 
U.S. TREASURY OBLIGATIONS -  99.3%        
U.S. Treasury Notes        
6.125%, 11/15/2027 (1)  $560,000   $712,202 
2.250%, 12/31/2023 (1)   488,000    481,904 
2.250%, 11/15/2025 (1)   528,000    516,723 
2.250%, 11/15/2024 (1)   512,000    503,381 
2.125%, 12/31/2022 (1)   472,000    465,484 
2.000%, 12/31/2021 (1)   456,000    449,856 
2.000%, 11/15/2026 (1)   536,000    512,184 
1.750%, 12/31/2020 (1)   440,000    433,729 
1.625%, 12/31/2019   424,000    419,817 
           
Total U.S. Treasury Obligations          
(Cost  $4,453,987)        4,495,280 
           
Total Investments - 99.3%          
(Cost  $4,453,987)       $4,495,280 

 

Percentages are based on net assets of $4,526,860.

 

A list of the open futures contracts held by the Fund at December 31, 2018, is as follows:

 

   Number of             Unrealized 
   Contracts  Expiration  Notional       Appreciation 
Type of Contract  Long (Short)  Date  Amount   Value   (Depreciation) 
S&P 500 Annl Div  Dec19  40  12/23/2019  $561,699   $566,000   $4,301 
S&P 500 Annl Div  Dec20  40  12/21/2020   588,886    565,000    (23,886)
S&P 500 Annl Div  Dec21  40  12/20/2021   616,761    569,000    (47,761)
S&P 500 Annl Div  Dec22  40  12/19/2022   637,699    575,000    (62,699)
S&P 500 Annl Div  Dec23  40  12/18/2023   655,011    579,500    (75,511)
S&P 500 Annl Div  Dec24  40  12/23/2024   674,699    588,500    (86,199)
S&P 500 Annl Div  Dec25  40  12/22/2025   691,386    595,500    (95,886)
S&P 500 Annl Div  Dec26  40  12/21/2026   708,574    607,000    (101,574)
S&P 500 Annl Div  Dec27  40  12/20/2027   726,198    618,500    (107,698)
Net Unrealized Appreciation (Depreciation)                  $(596,913)

 

Risk and volume is representative of the period.

 

(1)Security, or a portion of these securities, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended December 31, 2018 was $513,627 or 11.3% of net assets.

 

See accompanying notes to financial statements.

 

4

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Statements of Operations

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
         
Investment Income        
Interest Income  $26,174   $11,619 
           
Expenses          
Advisory Fees   5,603    2,644 
Administration Fees   18,493    11,096 
Professional Fees   11,713    776 
Custody Fees   214    224 
Tax Preparation Fees   23,918    1,584 
Other Expenses   12,211    1,340 
Total Expenses   72,152    17,664 
Less Waivers/Reimbursement of:          
Voluntary Waivers   (66,548)   - 
Net Expenses   5,604    17,664 
Net Investment Income (Loss)   20,570    (6,045)
           
Net Realized and Unrealized Gain (Loss) from Investment Activities          
Net Realized Gain (Loss) on Investments   3,813    (856)
Net Realized Gain (Loss) on Futures Contracts   (72,850)   - 
Net Change in Unrealized Appreciation (Depreciation) on Investments   44,972    4,142 
Net Change in Unrealized Appreciation (Depreciation) on Futures Contracts   410,924    78,701 
Net Realized and Unrealized Gain (Loss) on Investments   386,859    81,987 
Net Increase (Decrease) in Net Assets Resulting from Operations  $407,429   $75,942 

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

5

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Statements of Changes in Shareholders’ Equity

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
Operations:        
Net Investment Income  $20,570   $(6,045)
Net Realized Gain (Loss) on Investments and Futures Contracts   (69,037)   (856)
Net Change in Unrealized Appreciation (Depreciation) on          
Investments and Futures Contracts   455,896    82,843 
Net Increase (Decrease) in Net Assets Resulting from Operations   407,429    75,942 
           
Dividends and Distributions to Shareholders:          
Investment Income   (91,000)   (36,500)
Total Dividends and Distributions   (91,000)   (36,500)
           
Capital Share Transactions:          
Issued   597,392    3,426,961 
Redeemed   (1,195,534)   - 
Net Increase (Decrease) in Net assets Resulting from Capital Share Transactions   (598,142)   3,426,961 
           
Total Increase (Decrease) in Net Assets   (281,713)   3,466,403 
           
Net Assets:          
Beginning of period   4,526,860    1,000 
End of period  $4,245,147   $3,467,403 
           
Capital Share Transactions:          
Beginning of Period   400,000    - 
Issued   50,000    250,000 
Redeemed   (100,000)   - 
Shares Outstanding from Capital Share Transactions   350,000    250,000 

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

6

 

 

U.S. Equity Cumulative Dividends Fund─Series 2027

Statements of Cash Flows

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
Cash Flows from operating activities        
Net increase/(decrease) in net assets from operating activities  $407,429    75,942 
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:          
Purchases of investments   (598,423)   (3,492,821)
Proceeds from sale of investments   965,597    110,792 
Accretion of discounts and amortization of premiums   (1,987)   - 
Net realized (gain)/loss on investments   (3,813)   856 
Net change in unrealized appreciation on investments   (44,972)   (4,142)
(Increase)/decrease in operating assets          
Cash pledged as collateral on futures contracts   (16,991)   (52,738)
Interest receivable   (23,874)   (27,575)
Receivable from advisor   950    - 
Variation margin receivable on open futures contracts   (9,188)   (32,500)
Deferred offering costs   (86)   (124,500)
Increase/(decrease) in operating liabilities          
Due to advisor   -    1,705 
Payable to administrator   (3,185)   6,370 
Variation margin payable on open futures contracts   (22,375)   - 
Other accrued expenses   46,903    3,923 
Net cash provided by (used in) operating activities   695,985    (3,534,688)
           
Cash Flows from financing activities          
Proceeds from capital share issuances   597,392    3,426,961 
Capital share redemptions   (1,195,534)   - 
Dividends and distributions to shareholders   (103,250)   (14,000)
Net cash provided by (used in) financing activities   (701,392)   3,412,961 
           
Net change in cash and cash equivalents   (5,407)   (121,727)
Cash and cash equivalents, beginning of period   212,744    125,500 
Cash and cash equivalents, end of period  $207,337   $3,773 
           
Supplemental Disclosure of Cash Flow and Non-Cash Information:          
Income Distribution Payable  $43,750   $22,500 

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

7

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Statements of Financial Condition

 

   (Unaudited)   (Audited) 
   March 31,
2019
   December 31,
2018
 
Assets        
Investments, at Fair Value (Cost $13,747,799 and $11,249,881, respectively)  $13,750,235   $11,248,789 
Cash and Cash Equivalents   254,514    69,630 
Cash pledged as collateral on Futures Contracts   489,965    1,218,374 
Variation Margin Receivable   109,375    137,813 
Receivable from Advisor   5,422    14,042 
Deferred Offering Costs   122,898    122,898 
Total Assets  $14,732,409   $12,811,546 
           
Liabilities          
Due to Advisor   124,500    124,500 
Payable to Administrator   -    3,185 
Variation Margin Payable on Open Futures Contracts   6,562    - 
Other Accrued Expenses   242,007    188,034 
Total Liabilities  $

373,069

   $315,719 
           
Shareholders’ Equity          
Authorized Participants (250,000 Shares Outstanding for each period presented, respectively)  $14,359,340   $12,495,827 
Net Asset Value Per Share  $57.44   $49.98 
Market Price Per Share  $57.33   $49.63 

 

See accompanying notes to financial statements.

 

8

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Schedule of Investments

March 31, 2019 (Unaudited)

 

Description  Principal
Amount
   Value 
U.S. TREASURY OBLIGATIONS - 95.8%        
U.S. Treasury Bills (1) (2) 2.451%, 8/15/2019  $13,875,000   $13,750,235 
Total U.S. Treasury Obligations          
(Cost $13,747,799)        13,750,235 
           
Total Investments - 95.8%          
(Cost $13,747,799)       $13,750,235 

 

Percentages are based on net assets of $14,357,738.

 

A list of the open futures contracts held by the Fund at March 31, 2019, is as follows:

 

   Number of              Unrealized 
  Contracts   Expiration  Notional       Appreciation 
Type of Contract  Long/(Short)   Date  Amount   Value   (Depreciation) 
S&P 500 Annl Div  Dec19  (25)   12/23/2019  $(349,301)  $(359,063)  $(9,762)
S&P 500 Annl Div  Dec20  (25)   12/21/2020   (366,801)   (369,687)  $(2,886)
S&P 500 Annl Div  Dec21  (25)   12/20/2021   (385,489)   (375,312)  $10,177 
S&P 500 Annl Div  Dec22  (25)   12/19/2022   (398,364)   (381,562)  $16,802 
S&P 500 Annl Div  Dec23  (25)   12/18/2023   (407,739)   (388,438)  $19,301 
S&P 500 Annl Div  Dec24  (25)   12/23/2024   (419,614)   (399,376)  $20,238 
S&P 500 Annl Div  Dec25  (25)   12/22/2025   (428,926)   (406,250)  $22,676 
S&P 500 Annl Div  Dec26  (25)   12/21/2026   (438,676)   (412,812)  $25,864 
S&P 500 Annl Div  Dec27  (25)   12/20/2027   (448,864)   (419,063)  $29,801 
S&P 500 Index Jun19  25   06/20/2019   17,431,338    17,736,251   $304,913 
Net Unrealized Appreciation (Depreciation)              $437,124 

 

(1)Zero coupon security. The rate reported on the Schedule of Investments is the effective yield at time of purchase.

 

(2)Security, or a portion of these securities, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended March 31, 2019 was $5,579,330 or 38.9 % of net assets.

 

See accompanying notes to financial statements.

 

9

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Schedule of Investments

December 31, 2018 (Audited)

 

Description  Principal
Amount
   Value 
U.S. TREASURY OBLIGATIONS -  90.0%        
U.S. Treasury Bills (1) (2) 2.414%, 4/11/2019  $11,325,000   $11,248,789 
Total U.S. Treasury Obligations          
(Cost $11,249,881)        11,248,789 
           
Total Investments - 90.0%          
(Cost $11,249,881)       $11,248,789 

 

Percentages are based on net assets of $12,495,827.

 

A list of the open futures contracts held by the Fund at December 31, 2018, is as follows:

 

   Number of              Unrealized 
  Contracts   Expiration  Notional       Appreciation 
Type of Contract  Long/(Short)   Date  Amount   Value   (Depreciation) 
S&P 500 Annl Div  Dec19  (25)    12/23/2019  $(349,301)  $(353,750)  $(4,449)
S&P 500 Annl Div  Dec20  (25)    12/21/2020   (366,801)   (353,125)   13,676 
S&P 500 Annl Div  Dec21  (25)    12/20/2021   (385,489)   (355,625)   29,864 
S&P 500 Annl Div  Dec22  (25)    12/19/2022   (398,364)   (359,375)   38,989 
S&P 500 Annl Div  Dec23  (25)    12/18/2023   (407,739)   (362,188)   45,551 
S&P 500 Annl Div  Dec24  (25)    12/23/2024   (419,614)   (367,813)   51,801 
S&P 500 Annl Div  Dec25  (25)    12/22/2025   (428,926)   (372,188)   56,739 
S&P 500 Annl Div  Dec26  (25)    12/21/2026   (438,676)   (379,375)   59,301 
S&P 500 Annl Div  Dec27  (25)    12/20/2027   (448,864)   (386,562)   62,302 
S&P 500 Index Mar19  25    03/15/2019   16,282,900    15,657,500    (625,400)
Net Unrealized Appreciation (Depreciation)                    $(271,626)

 

Risk and volume is representative of the period.

 

(1)Zero coupon security. The rate reported on the Schedule of Investments is the effective yield at time of purchase.
(2)Security, or a portion of these securities, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended December 31, 2018 was $3,059,980 or 24.5% of net assets.

 

See accompanying notes to financial statements.

 

10

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Statements of Operations

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
Investment Income        
Interest Income  $79,488   $25,361 
           
Expenses          
Advisory Fees   9,751    5,102 
Administration Fees   18,493    11,096 
Professional Fees   11,716    1,210 
Custody Fees   267    449 
Tax Preparation Fees   23,918    2,471 
Other Expenses   15,891    2,178 
Total Expenses   80,036    22,506 
Less Waivers/Reimbursement of:          
Voluntary Waivers   (35,141)   - 
Net Expenses   44,895    22,506 
Net Investment Income   34,593    2,855 
           
Net Realized and Unrealized Gain (Loss) from Investment Activities          
Net Realized Gain (Loss) on Investments   (370)   103 
Net Realized Gain (Loss) on Futures Contracts   1,117,012    437,717 
Net Change in Unrealized Appreciation (Depreciation) on Investments   3,528    2,260 
Net Change in Unrealized Appreciation (Depreciation) on Futures Contracts   708,750    (613,075)
Net Realized and Unrealized Gain (Loss) on Investments   1,828,920    (172,995)
Net Increase (Decrease) in Net Assets Resulting from Operations  $1,863,513   $(170,140)

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

11

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Statements of Changes in Shareholders’ Equity

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
Operations:        
Net Investment Income  $34,593   $2,855 
Net Realized Gain (Loss) on Investments and Futures Contracts   1,116,642    437,820 
Net Change in Unrealized Appreciation (Depreciation) on Investments and Futures Contracts   712,278    (610,815)
Net Increase (Decrease) in Net Assets Resulting from Operations   1,863,513    (170,140)
           
Capital Share Transactions:          
Issued/Redeemed   -    13,144,749 
Net Increase in Net Assets Resulting from Capital Share Transactions   -    13,144,749 
           
Total Increase in Net Assets   1,863,513    12,974,609 
           
Net Assets:          
Beginning of period   12,495,827    1,000 
End of period  $14,359,340   $12,975,609 
           
Capital Share Transactions:          
Beginning of Period   250,000    - 
Issued   -    250,000 
Shares Outstanding from Capital Share Transactions   250,000    250,000 

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

12

 

 

U.S. Equity Ex-Dividend Fund─Series 2027

Statements of Cash Flows

(Unaudited)

 

   Three Months Ended
March 31,
 
   2019   2018* 
Cash Flows from operating activities        
Net increase/(decrease) in net assets from operating activities  $1,863,513    (170,140)
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:          
Purchases of investments   (15,478,981)   (26,895,177)
Proceeds from sale of investments   13,056,455    14,578,964 
Accretion of discounts and amortization of premiums   (75,762)   - 
Net realized (gain)/loss on investments   370    (103)
Net change in unrealized (appreciation)/depreciation on investments   (3,528)   (2,260)
(Increase)/decrease in operating assets          
Cash pledged as collateral on futures   728,409    (188,302)
Variation margin receivable on open futures contracts   28,438    (221,250)
Receivable from advisor   8,620    - 
Deferred offering costs   -    (124,500)
Increase/(decrease) in operating liabilities          
Due to advisor   -    3,269 
Payable to administrator   (3,185)   6,370 
Variation margin payable on open futures contracts   6,562    32,500 
Other accrued expenses   53,973    6,308 
Net cash provided by (used in) operating activities   184,884    (12,974,321)
           
Cash Flows from financing activities          
Proceeds from capital share issuances   -    13,144,749 
Net cash provided by financing activities   -    13,144,749 
           
Net change in cash and cash equivalents   184,884    170,428 
Cash and cash equivalents, beginning of period   69,630    125,500 
Cash and cash equivalents, end of period  $254,514   $295,928 

 

*The Fund’s commencement of operations was January 17, 2018

 

See accompanying notes to financial statements.

 

13

 

 

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

NOTE 1 – ORGANIZATION

 

Metaurus Equity Component Trust (the “Trust”) was formed in September 2016 and is authorized to have multiple series or portfolios. The Trust is a statutory trust formed under the laws of the state of Delaware. The Trust currently has two series or funds traded on the NYSE Arca, Inc. exchange (“NYSE Arca”), U.S. Equity Cumulative Dividends Fund─Series 2027 (the “Dividend Fund”) and U.S. Equity Ex-Dividend Fund─Series 2027 (the “Ex-Dividend Fund”, each a “Fund” or “ETF”) collectively the “Funds” or “ETFs”). Metaurus Advisors LLC (the “Sponsor” or “Advisor”) serves as the sponsor, commodity pool operator and commodity trading advisor of each Fund. Each of the Funds commenced operations on January 17, 2018 and commenced investment operations on February 5, 2018.

 

The Trust has had no investment operations prior to February 5, 2018 other than matters relating to its organization, the registration of each series/Fund under the Securities Act of 1933, as amended, and matters relating to their establishment and the capital contribution by the Sponsor of $1,000 to each Fund on December 22, 2017.

 

The investment objective of the ETFs is to employ a passive management, or indexing, investment approach designed to correspond to the performance of each underlying index, before fees and expenses.

 

Individual Shares of the ETFs may be purchased and sold only on a national securities exchange, an alternative trading system or in the over-the-counter market and not directly from the ETFs. Only broker-dealers who have entered into agreements with the Trust to act as authorized participants of the Trust (“Authorized Participants”) may purchase or redeem shares directly with the ETFs. Shares of the ETFs are listed and traded on the NYSE Arca, Inc. exchange. The Fund will issue and redeem Shares on a continuous basis, through SEI Investments Distribution Co. (the “Distributor”), at net asset value (“NAV”) per Share only in one or more large blocks of 50,000 Shares, called “Baskets”. Baskets may be issued and redeemed for cash but are expected to be issued and redeemed principally through exchange for related positions (“EFRP”) transactions for (i) futures contracts, Treasury securities and other financial instruments designed to track such Fund’s underlying index (“Deposit Instruments”) and (ii) a cash amount that includes a variable charge. Creation and redemption prices of Baskets are directly linked to a Fund’s next computed NAV and will vary from NAV by a market-determined trading cost, which may be zero. Shares generally will trade in the secondary market in amounts less than a Basket at market prices that change throughout the day. Trading prices in the secondary market for the Shares may be different from the NAVs of the ETFs.

 

Undefined capitalized terms shall have the meaning as set forth in the registration statement.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 Financial Services — Investment Companies. As such, the ETFs follow the investment company accounting and reporting guidance.

 

The accompanying unaudited financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

  

14

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

Following is a summary of the significant accounting policies followed by the Funds:

 

Basis of Presentation, Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Concentration of Credit Risk

 

Credit risk is the risk that a financial loss will be incurred if a Fund’s counterparty does not fulfill its financial obligations in a timely manner. Financial instruments that potentially subject the Funds to concentrations of credit risk consist principally of investments and cash deposits. Investments and cash of each Fund at March 31, 2019 are held at Brown Brothers, Harriman & Co., Morgan Stanley & Co. LLC, and First Republic Bank.

 

Final Net Asset Value for Fiscal Period

 

The NAV per Share for a Fund is determined by dividing the net assets of the Fund by the number of outstanding Shares. The NAVs of the ETFs are determined as soon as practicable after the close of regular trading of the Shares on the NYSE Arca on each Business Day. Each Fund’s net assets on a Business Day is obtained by subtracting accrued expenses and other liabilities borne by such Fund, if any, from the total value of the assets held by the Fund, in each case, as of the time of calculation. SEI Investments Global Fund Services, Inc., the administrator of the ETFs is responsible for making these determinations.

 

Fair Value of Financial Instruments

 

Security Valuation — Securities listed on a securities exchange, market or automated quotation system for which quotations are readily available (except for securities traded on NASDAQ), including securities traded over the counter, are valued at the last quoted sale price on the primary exchange or market (foreign or domestic) on which they are traded (or at approximately 4:00 pm Eastern Time if a security’s primary exchange is normally open at that time), or, in the case of the futures contracts held by the Funds, at the daily settlement price published by the Chicago Mercantile Exchange for such futures contracts. For securities traded on NASDAQ, the NASDAQ Official Closing Price will be used.

 

Treasury Securities held by the Funds generally are priced based upon valuations provided by independent, third-party pricing agents.

 

Securities for which market prices are not “readily available” are valued in accordance with Fair Value Procedures established by the Sponsor or a committee of its personnel thereof. Some of the more common reasons that may necessitate that a security be valued using Fair Value Procedures include: the security’s trading has been halted or suspended; the security has been de-listed from a national exchange; the security’s primary trading market is temporarily closed at a time when under normal conditions it would be open; the security has not been traded for an extended period of time; the security’s primary pricing source is not able or willing to provide a price; or trading of the security is subject to local government-imposed restrictions. In addition, the Funds may fair value their securities if an event that may materially affect the value of a Fund’s securities that traded outside of the United States (a “Significant Event”) has occurred between the time of the security’s last close and the time that the Fund calculates its net asset value. A Significant Event may relate to a single issuer or to an entire market sector. Events that may be Significant Events include: government actions, natural disasters, armed conflict, acts of terrorism and significant market fluctuations. If the Advisor becomes aware of a Significant Event that has occurred with respect to a security or group of securities after the closing of the exchange or market on which the security or securities principally trade, but before the time at which the Fund calculates its net asset value, it may request that a valuation meeting be called. When a security is valued in accordance with the Fair Value Procedures, the Sponsor or its designees will determine the fair value after taking into consideration relevant information reasonably available to it.

 

15

 

  

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

In accordance with the authoritative guidance on fair value measurements and disclosure under GAAP, the Funds disclose fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure the fair value. The objective of a fair value measurement is to determine the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). Accordingly, the fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).The three levels of the fair value hierarchy are described below:

 

  Level 1 Unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities that the Fund has the ability to access at the measurement date;
       
  Level 2 Quoted prices which are not active, or inputs that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and
       
  Level 3 Prices, inputs or exotic modeling techniques which are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

In some instances, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls shall be determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

The following table summarizes the inputs used to value the Funds’ investments at March 31, 2019 and December 31, 2018 using the fair value hierarchy:

 

U.S. Equity Cumulative Dividends Fund─Series 2027

March 31, 2019 (Unaudited)

 

Investments in Securities  Level 1   Level 2   Level 3   Total 
                 
U.S. Treasury Obligations  $   -   $4,178,878   $   -   $4,178,878 
Total Investments in Securities  $-   $4,178,878   $-   $4,178,878 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
                 
Futures Contracts*                
Unrealized Appreciation  $7,571   $   -   $   -   $7,571 
Unrealized Depreciation   (193,560)   -    -    (193,560)
Total Other Financial Instruments  $(185,989)  $-   $-   $(185,989)

 

U.S. Equity Cumulative Dividends Fund─Series 2027

December 31, 2018 (Audited)

 

Investments in Securities  Level 1   Level 2   Level 3   Total 
                 
U.S. Treasury Obligations  $   -   $4,495,280   $   -   $4,495,280 
Total Investments in Securities  $-   $4,495,280   $-   $4,495,280 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
                 
Futures Contracts*                
Unrealized Appreciation  $4,301   $   -   $   -   $4,301 
Unrealized Depreciation   (601,214)   -    -    (601,214)
Total Other Financial Instruments  $(596,913)  $-   $-   $(596,913)

 

*Futures contracts are valued at unrealized appreciation (depreciation) on the instrument.

 

For the periods ended March 31, 2019 and December 31, 2018, there have been no transfers between Level 1, Level 2, or Level 3 investments. It is the Funds’ policy to recognize transfers into and out of Level 1, Level 2 and Level 3 at the end of the reporting period. For the period ended March 31, 2019 and December 31, 2018, there were no Level 3 investments.

 

Amounts designated as “-” are $0.

  

16

 

 

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

U.S. Equity Ex-Dividend Fund─Series 2027

March 31, 2019 (Unaudited)

 

Investments in Securities  Level 1   Level 2   Level 3   Total 
                 
U.S. Treasury Obligations  $   -   $13,750,235   $   -   $13,750,235 
Total Investments in Securities  $-   $13,750,235   $-   $13,750,235 

  

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
                 
Futures Contracts*                
Unrealized Appreciation  $449,772   $   -   $   -   $449,772 
Unrealized Depreciation   (12,648)   -    -    (12,648)
Total Other Financial Instruments  $437,124   $-   $-   $437,124 

 

U.S. Equity Ex-Dividend Fund─Series 2027

December 31, 2018 (Audited)

 

Investments in Securities  Level 1   Level 2   Level 3   Total 
                 
U.S. Treasury Obligations  $   -   $11,248,789   $   -   $11,248,789 
Total Investments in Securities  $-   $11,248,789   $-   $11,248,789 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
                 
Futures Contracts*                
Unrealized Appreciation  $358,223   $   -   $   -   $358,223 
Unrealized Depreciation   (629,849)   -    -    (629,849)
Total Other Financial Instruments  $(271,626)  $-   $-   $(271,626)

 

*Futures contracts are valued at unrealized appreciation (depreciation) on the instrument.

 

For the periods ended March 31, 2019 and December 31, 2018, there have been no transfers between Level 1, Level 2, or Level 3 investments. It is the Funds’ policy to recognize transfers into and out of Level 1, Level 2 and Level 3 at the end of the reporting period. For the period ended March 31, 2019 and December 31, 2018, there were no Level 3 investments.

 

Amounts designated as “-” are $0.

  

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

 

Investment transactions are recorded on trade date. Dividend income is recorded on the ex-dividend date. Discounts and premiums on securities purchased are amortized or accreted using the effective interest method. Realized gains and losses from securities transactions and unrealized appreciation and depreciation of securities are determined using the identified cost basis method for financial reporting.

 

Trading and Transaction Costs and Fees

 

Each Fund will pay (or will reimburse the Clearing FCM if previously paid) any other transaction costs and fees associated with trading of the Fund’s instruments (including floor brokerage, exchange, clearing, give-up, user and National Futures Association (“NFA”) fees) that are not related to the creation and redemption of Baskets.

 

Income Taxes

 

Each Fund is a series of a Delaware statutory trust and will be treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax; rather each beneficial owner of Shares will be required to take into account its allocable share of the Fund’s income, gain, loss deductions and other items for the Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

The Funds file an income tax return in the U.S. federal jurisdiction and may file income tax returns in various U.S. states and foreign jurisdictions. Generally, the Funds are subject to income tax examinations by federal, state and local jurisdictions, where applicable.

 

The Funds are required to determine whether their tax positions are more likely than not to be sustained upon examination by the applicable taxing authority based on the technical merits of the position. Tax positions not deemed more-likely-than-not threshold would be recorded as a tax expense in the current period. 

17

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

At March 31, 2019 and December 31, 2018, the Funds had no unrecognized tax benefits related to their tax positions. The Funds do not expect that their assessments related to unrecognized tax benefits will materially change over the next 12 months. However, the Funds’ conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, the nexus of income among various tax jurisdictions; compliance with U.S. federal, state and foreign tax laws; and changes in the administrative practices and precedents of the relevant taxing authorities.

 

The Funds’ policy is to classify interest and penalties associated with the failure to file U.S. federal and state income tax returns, as income tax expenses on their Statements of Operations. For the period January 17, 2018 (commencement of operations) through  March 31, 2018 and for the three months ended March 31, 2019, the Funds did not have any interest or penalties associated with the failure to file any income tax returns.

 

Distribution Policy

 

The Dividend Fund expects to pay monthly cash distributions to its Shareholders throughout each calendar year. Such distributions shall, on an annual basis, before fees and expenses, equal all or a substantial portion of the Dividend Fund’s NAV attributable to the ordinary cash dividends accumulated by the Dividend Points Index for the year (as reflected in the current year’s S&P 500 Dividend Futures Contracts held by the Dividend Fund). Such distributions may consist of ordinary income, capital gains and/or return of capital whose character will be determined at fiscal year-end once final year-end figures have been calculated. The Dividend Fund’s capital gains, if any, for a calendar year may include any net unrealized appreciation in its futures contracts that expire in future calendar years.

 

The Ex-Dividend Fund does not anticipate making any periodic distributions.

 

NOTE 3 – INVESTMENTS

 

The Dividend Fund seeks investment results that, before fees and expenses, correspond to the performance of the Solactive® U.S. Cumulative Dividends Index—Series 2027 (the “Solactive Dividend Index”) over each calendar year so as to provide Shareholders with returns designed to replicate the dividends on constituent companies of the S&P 500, without exposure to the underlying securities. The Dividend Fund intends primarily to invest its assets in the component instruments of the Solactive Dividend Index, as well as in cash and/or cash equivalents. The component instruments of the Solactive Dividend Index consist of U.S. Treasury Securities (“Treasury Securities”) and long positions in annual futures contracts listed on the Chicago Mercantile Exchange (“CME”) that provide exposure to dividends paid on the S&P 500 constituent companies (“S&P 500 Dividend Futures Contracts”) pro rata for each year of the life of the Dividend Fund.

 

The Ex-Dividend Fund seeks investment results that, before fees and expenses, correspond to the performance of the Solactive® U.S. Equity Ex-Dividends Index—Series 2027 (the “Solactive Ex-Dividend Index”). The Ex-Dividend Fund seeks to track the Solactive Ex-Dividend Index so as to provide Shareholders with returns that are equivalent to the performance of 0.25 shares of SPDR S&P 500 exchange-traded fund (“SPY”) less the value of current and future expected ordinary cash dividends to be paid on the S&P 500 constituent companies over the term of the Ex-Dividend Fund. SPY is an exchange-traded fund that seeks to track the S&P 500. The Ex-Dividend Fund seeks to replicate the performance of SPY through owning long positions in quarterly S&P 500 Index futures contracts traded on the CME (“S&P 500 Index Futures Contracts”) rather than shares of SPY. Additionally, the Ex-Dividend Fund intends to track the performance of the Solactive Ex-Dividend Index by selling S&P 500 Dividend Futures Contracts. The Ex-Dividend Fund will also hold Treasury Securities, cash and/or cash equivalents.

 

Short-Term Investments

 

The Funds may purchase U.S. Treasury Bills, cash and or cash equivalents. Additionally, the Funds may enter into short-term loans and reverse repurchase agreements for liquidity purposes. There were no short-term loans or reverse repurchase agreements held in the Funds as of and during the period ended March 31, 2019 nor as of and during the period from January 17, 2018 (commencement of operations) through March 31, 2018.

 

Accounting for Derivative Instruments

 

All open derivative positions at period end are reflected on each respective ETF’s Schedule of Investments. The ETFs utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objective during the period. While the volume of open positions may vary on a daily basis as each ETF transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective ETF at the date of this report is generally representative of open positions throughout the reporting period. Following is a description of the derivative instruments used by the ETFs during the reporting period, including the primary underlying risk exposures related to each instrument type.

 

Futures Contracts

 

The ETFs enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying index, currency or commodity, as set forth above. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract. The particular futures contracts utilized by the ETFs permit settlement only in cash. Upon entering into a futures contract, each ETF is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected.

18

 

 

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition and Schedules of Investments, and is restricted as to its use. The ETFs that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities.  Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction. Futures contracts involve, to varying degrees, elements of market risk (specifically commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the ETFs since futures contracts are exchange-traded and the exchange’s clearinghouse, as counterparty to all exchange-traded futures contracts, guarantees the futures contracts against default. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk that the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

 

The Funds held futures equity contracts as of and for the three-month period ended March 31, 2019 and as of and for the period ended December 31, 2018. The value and detail of these contracts are disclosed on their Schedule of Investments. The corresponding gains and losses associated with these contracts are disclosed on the respective each Fund’s respective Statement of Operations.

 

The average volume of futures contracts for the three-month period ended March 31, 2019 are as follows:

 

U.S. Equity Cumulative Dividends Fund─Series 2027

 

Derivative  Notional Amount 
Long futures contracts  $4,638,707 

 

U.S. Equity Ex-Dividend Fund─Series 2027

 

Derivative  Notional Amount 
Long futures contracts  $16,665,713 
Short futures contracts  $(3,643,774)

 

The average volume of futures contracts during the period February 5, 2018 (commencement of investment operations) to March 31, 2018 are as follows:

 

U.S. Equity Cumulative Dividends Fund─Series 2027

 

Derivative  Notional Amount 
Long futures contracts  $3,572,407 

 

U.S. Equity Ex-Dividend Fund─Series 2027

 

Derivative  Notional Amount 
Long futures contracts  $15,120,733 
Short futures contracts  $(3,570,968)

 

Offsetting Assets and Liabilities

 

The Futures Account Agreement includes provisions permitting the Clearing FCM to net and set off its obligations to the Fund against the obligations of the Fund to the Clearing FCM upon the termination of the agreement or occurrence of an Event of Default, as defined in the agreement. As described above, the Funds utilize derivative instruments to pursue their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

 

19

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of March 31, 2019.

 

March 31, 2019 (Unaudited)

U.S. Equity Cumulative Dividends Fund─Series 2027

Offsetting of Derivative Assets

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Assets
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Assets
Futures Contracts  $9,188   $       -   $9,188   $       -   $       -   $9,188 
Total  $9,188   $-   $9,188   $-   $-   $9,188 

 

Offsetting of Derivative Liabilities

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Liabilities
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged (a)
   Net Amount 
Derivative Liabilities
Futures Contracts  $(6,125)  $      -   $(6,125)  $        -   $6,125   $        - 
Total  $(6,125)  $-   $(6,125)  $-   $6,125   $- 

 

December 31, 2018 (Audited)

Offsetting of Derivative Assets

  

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Assets
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Assets                              
Futures Contracts  $        -   $    -   $      -   $         -   $          -   $        - 
Total  $-   $-   $-   $-   $-   $- 

 

Offsetting of Derivative Liabilities

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the  Statement of Financial Condition 
   Recognized
Liabilities
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Liabilities
Futures Contracts  $(28,500)            $(28,500)  $           -   $28,500   $       - 
Total  $(28,500)       $(28,500)  $-   $28,500   $- 

 

(a)These amounts are limited to the derivatives asset/liability balance and, accordingly, do not include excess collateral received/pledged.

 

20

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

U.S. Equity Ex-Dividends Fund─Series 2027

March 31, 2019 (Unaudited)

Offsetting of Derivative Assets

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Assets
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Assets
Futures Contracts  $109,375   $       -   $109,375   $       -   $       -   $109,375 
Total  $109,375   $-   $109,375   $-   $-   $109,375 

 

Offsetting of Derivative Liabilities

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Liabilities
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Liabilities
Futures Contracts  $(6,562)  $       -   $(6,562)  $            -   $6,562   $          - 
Total  $(6,562)  $-   $(6,562)  $-   $6,562   $- 

 

December 31, 2018 (Audited)

Offsetting of Derivative Assets

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Assets
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged(a)
   Net Amount 
Derivative Assets
Futures Contracts  $137,813   $       -   $137,813   $           -   $           -   $137,813 
Total  $137,813   $-   $137,813   $-   $-   $137,813 

 

Offsetting of Derivative Liabilities

 

   Gross Amounts of   Gross Amounts Offset in the Statement of   Net Amounts Presented in the Statement of   Gross Amounts Not Offset in the Statement of Financial Condition 
   Recognized
Liabilities
   Financial
Condition
   Financial
Condition
   Financial
Instruments(a)
   Cash Collateral
Pledged (a)
   Net Amount 
Derivative Liabilities
Futures Contracts  $        -   $      -   $     -   $         -   $           -   $        - 
Total  $-   $-   $-   $-   $-   $- 

 

(a)These amounts are limited to the derivatives asset/liability balance and, accordingly, do not include excess collateral received/pledged.

  

21

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

NOTE 4 – AGREEMENTS

 

Sponsor

 

The Sponsor has entered into an agreement (the “Reimbursement Agreement”) with the Funds to reimburse the Sponsor for amounts provided to the Funds to pay for the fees to register the offering of the Shares with the Securities and Exchange Commission. The amount due to the Sponsor, as disclosed on the Statements of Financial Condition, will be repaid over a maximum ten-year period. The amount reimbursed to the Sponsor by a Fund over a given calendar year will vary depending on the number of Shares issued by the Fund during such year. The Reimbursement Agreement contains a prepayment provision where upon issuance of any shares of the Funds, the prorated portion of the amount due based on the percentage of shares issued to the percentage of the overall shares registered is due within 90 days of the share issuance date. In addition, should the Funds terminate prior to the full repayment of the amount due, the Sponsor has agreed to forfeit the unpaid amount. There is no interest charged on the amounts due and no amounts have been paid to date.

 

Each Fund pays its periodic professional expenses, including, but not limited to the fees of the Trustee, continuous offering expenses, legal, audit, tax, accounting, performance, administrative, filing, reporting and data processing fees and expenses and other operating expenses. For each Fund, the Sponsor has agreed to pay any professional expenses of each Fund in excess of $150,000 in each of 2018 and 2019. The Funds are responsible for any extraordinary expenses and liabilities. Each Fund pays its printing and mailing expenses.

 

While neither of the Funds have individually incurred professional expenses in excess of $150,000 through March 31, 2019, the Sponsor has elected to voluntarily reimburse certain expenses beginning on January 1, 2019 totaling $66,548 and $35,141 for the Dividend Fund and Ex-Dividend Fund, respectively. There were no voluntary waivers from January 17, 2018 (commencement of operations) through March 31, 2018 for either Fund. The Sponsor’s voluntary reimbursement of such expenses may be modified or terminated at any time at the option of the sponsor.

 

Administrator, Custodian, Fund Accountant and Transfer Agent

 

SEI Investments Global Fund Services, Inc. (the “Administrator”) serves as the Funds’ Administrator pursuant to an administration agreement. Brown Brothers Harriman & Co. (the “Custodian”) serves as the Funds’ custodian and transfer agent pursuant to a custodian and transfer agent agreement.

 

Clearing FCM

 

Morgan Stanley & Co. LLC (“MS&Co.” or the “Clearing FCM”) serves as the Fund’s Clearing FCM pursuant to the terms of a commodity futures customer agreement among the Sponsor, on behalf of the Funds, severally and not jointly, and the Clearing FCM (the “Futures Account Agreement”). As Clearing FCM, MS&Co. serves as the Funds’ clearing broker and as such arranges for the execution and clearing of the Funds’ futures transactions. As such, MS&Co. holds, on behalf of the Funds, positions in futures contracts and Treasury Securities, cash and cash equivalents as futures margin. Treasury Securities, cash and cash equivalents not held as futures margin will be held by the Custodian. The Funds may engage additional and/or other futures commission merchants in the future.

 

Distribution Agreement

 

SEI Investments Distribution Co., a wholly-owned subsidiary of SEI Investments and an affiliate of the Administrator, serves as the Funds’ distributor of Baskets pursuant to a distribution agreement. The Distributor does not maintain any secondary market in the Shares.

 

Management Fee/Advisory Fee

 

The Management Fee is paid to the Sponsor in consideration of its services as sponsor, commodity pool operator, commodity trading advisor, and for managing the business and affairs of the Funds. The Sponsor supervises and directs the investment of the assets of the Funds in accordance with the Funds’ investment objectives and investment strategies outlined in the Funds’ prospectus.

 

The Dividend Fund will pay the Sponsor a Management Fee equal to 0.58% per year of the Dividend Fund’s average daily NAV, calculated and payable monthly, subject to a minimum monthly fee of $0.005 per Share. This minimum monthly fee is expected to apply when the Dividend Fund’s average daily NAV for such month is less than $10.34 per Share.

 

The Ex-Dividend Fund will pay the Sponsor a Management Fee equal to 0.29% per year of the Ex-Dividend Fund’s average daily NAV, calculated and payable monthly.

 

22

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

NOTE 5 – OFFERING AND ORGANIZATIONAL COSTS

 

The Sponsor paid all necessary and reasonable expenses and liabilities incurred in connection with the organization of the Funds and proposed initial public offering of the Shares. Each Fund will reimburse the Sponsor for registration fees paid to the SEC in connection with the registration of the Fund’s Shares, which is represented on the Statements of Financial Position as Due to Advisor. Such amounts will be reimbursed over the term of the Fund without interest. The reimbursement amount may vary from year to year based on the amount of Shares issued during a year.

 

Deferred offering costs consist of fees paid in relation to legal, accounting, regulatory and work completed in preparation of equity offerings. Deferred offering costs are charged against the proceeds from equity offerings when received. As of March 31, 2019, deferred offering costs for each Fund, which are included on the Statements of Financial Condition, were $123,902 for the Dividend Fund and $122,898 for the Ex-Dividend Fund. As of December 31, 2018, deferred offering costs for each Fund, which are included on the Statements of Financial Condition, were $123,816 for the Dividend Fund and $122,898 for the Ex-Dividend Fund.

 

NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS

 

The Funds issue and redeem Shares on a continuous basis at NAV in one or more large blocks of 50,000 Shares called Baskets. Each Fund intends to create and redeem Baskets primarily through exchange for related position (“EFRP”) transactions. In certain instances, the Funds may effect creations and redemptions partly or wholly for cash, rather than through an EFRP transaction.

 

The manner by which redemptions are made is dictated by the terms of the respective authorized participant agreement between an Authorized Participant and the Trust (“Authorized Participant Agreement”). Except when aggregated in Baskets, Shares are not redeemable securities of a Fund. Shares of the Funds may be purchased or redeemed only by Authorized Participants. An Authorized Participant is an institution that (i) is a broker-dealer; (ii) is a registered futures commission merchant and/or clears through a registered futures commission merchant; (iii) is a Depository Trust Company Participant and a member of the National Securities Clearing Corporation; (iv) has entered into an Authorized Participant agreement with the Trust; and (v) is in a position to transfer the required Deposit Instruments and/or the cash to buy and sell whole Baskets. Investors will purchase Shares in the secondary market, generally with the assistance of a broker or investment advisor and will be subject to customary brokerage commissions, mark ups and mark downs and fees.

 

Authorized Participants will pay a transaction fee per Basket created or redeemed. The Sponsor may choose to pay transaction fees on behalf of Authorized Participants and has done so to date on Baskets that have been created. There is no guarantee that Sponsor will continue to do so. In addition, to the extent that cash is delivered or received in lieu of any of the Deposit Instruments upon the creation or redemption of Shares by an Authorized Participant, such Authorized Participants will pay an additional variable charge up to 2% of the cash that is delivered or received in lieu of any of the Deposit Instruments to a Fund to pay for any additional transaction costs and fees and price changes associated with the purchase or disposition of any of the Deposit Instruments.

 

NOTE 7 – FINANCIAL HIGHLIGHTS

 

Selected data for a Share outstanding throughout the three months ended March 31, 2019:

   

Financial Highlights
Three Months Ended March 31, 2019 (Unaudited)

  

           Net                           Net    Ratio of   Ratio of
Expenses
   Ratio of
Net
     
           Realized       Distributions                   Assets  

Expenses
   to Average   Investment     
   NAV   Net   and   Total   from Net       NAV           End of   to Average   Net Assets   Income/Loss     
   Beginning   Investment   Unrealized   from   Investment   Total   End of   Total   Market   Period   Net   (Excluding   to Average   Portfolio 
   of Period   Income/Loss*   Gain/Loss   Operations   Income   Distributions   Period   Return(1)   Price   (000)   Assets(3)   Waivers)(3)   Net Assets(3)   Turnover(2) 
U.S. Equity Cumulative Dividends Fund─Series 2027
2019  $11.32   $0.06   $1.03   $1.09   $(0.28)  $(0.28)  $12.13    9.67%  $12.16   $4,245    0.59%   7.55%   2.15%   14%
                                                                       
U.S. Equity Ex-Dividend Fund─Series 2027
2019  $49.98   $0.14   $7.31   $7.45   $-   $-   $57.44    14.91%  $57.33   $14,358    1.35%   2.41%   1.04%   0%

 

*Per share data calculated using average shares method.

(1)Total return is for the period indicated and has not been annualized.

(2)Portfolio turnover rate is for the period indicated and has not been annualized.

(3)Annualized.

 

Amounts designated as “-” are $0.

 

23

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

Financial Highlights

For the Period from January 17, 2018 (commencement of operations) to March 31, 2018

 

           Net Realized       Distributions                   Net Assets   Ratio of   Ratio of
Net Investment
     
   NAV   Net   and   Total   from Net       NAV           End of   Expenses   Income/Loss     
   Beginning   Investment   Unrealized   from   Investment   Total   End of   Total   Market   Period   to Average   to Average   Portfolio 
   of Period   Income/Loss*   Gain/Loss   Operations   Income   Distributions   Period   Return(1)   Price   (000)   Net Assets(4)   Net Assets(4)   Turnover(2) 
U.S. Equity Cumulative Dividends Fund─Series 2027
2018 (3)  $13.73   $(0.03)   $0.33  $0.30  $(0.16)  $(0.16)  $13.87    2.19%  $13.97   $3,467    3.80%   -1.30%   4%
                                                                  
U.S. Equity Ex-Dividend Fund─Series 2027
2018 (3)  $51.48   $0.01   $0.45(5)  $0.43  $-   $-   $51.91    0.84%  $51.08   $12,976    1.25%   0.16%   0%

 

*Per share data calculated using average shares method.

(1)Total return is for the period indicated and has not been annualized.

(2)Portfolio turnover rate is for the period indicated and has not been annualized.

(3)From commencement of operations, January 17, 2018 (inception) through March 31, 2018.

(4)Annualized.

(5)The amount shown for a share outstanding through out the period does not accord with the aggregate net loss on investments for the period because the sales and repurchase of Fund shares in relation to fluctuating market value of the Fund.

 

Amounts designated as “-” are $0.

 

NOTE 8 – RISK

 

Principal Risks

 

A shareholder of the Funds is subject to the risk that his or her investment could lose money. The Funds are subject to the principal risks noted below, any of which may adversely affect a Fund’s NAV, trading price, yield, total return and ability to meet its investment objective. A more complete description of principal risks is included in the prospectus under the heading “Principal Risks”. This could result in the Funds’ underperformance compared to other funds with similar investment objectives.

 

Market Trading Risks

 

Individual Shares may be purchased and sold only on a national securities exchange, an alternative trading system, or in the over-the-counter market and may not be directly purchased or redeemed from the Funds. There can be no guarantee that an active trading market for Shares will develop or be maintained, or that the listing of the Shares will continue unchanged. Buying and selling Shares may require a shareholder to pay brokerage commissions and expose a shareholder to other trading costs. Due to brokerage commissions and other transaction costs that may apply, frequent trading may detract from realized investment returns. Trading prices of Shares may be above, at or below the Funds’ NAV, will fluctuate in relation to NAV based on supply and demand in the market for Shares and other factors, and may vary significantly from NAV during periods of market volatility. The return on an investor’s investment will be reduced when the investor sells Shares at a discount or buys Shares at a premium to NAV.

 

24

 

   

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

 

Contingent Pricing Risks

 

Creation and redemption prices of Baskets are directly linked to the Funds’ next-computed NAV, which is normally determined at the end of each business day. Buyers and sellers of Shares will not know the value of their purchases and sales until the Funds’ NAV is determined at the end of the trading day. Like mutual funds, the Funds do not offer opportunities to purchase or redeem Baskets intraday at currently determined (as opposed to end-of-day) prices. Creation and redemption prices of Baskets are contingent upon the determination of NAV and may vary significantly from anticipated levels (including estimates based on intraday indicative values disseminated by the Funds) during periods of market volatility. Although limit orders can be used to restrict differences between prices of the Shares in the secondary market and NAV (i.e., premiums and discounts to NAV), they cannot be used to specify trade execution prices. However, unlike shares of mutual funds, Shares will trade on NYSE Arca, Inc. during the day at market-determined prices. The Funds will disseminate an indicative NAV every 15 seconds during the trading day.

 

Cash Transactions Risk

 

Each Fund intends to create and redeem Baskets primarily through EFRP transactions. In certain instances, the Funds may effect creations and redemptions partly or wholly for cash, rather than through an EFRP transaction. Because the Funds may effect redemptions for cash, rather than through an EFRP transaction, they may be required to sell Deposit Instruments in order to obtain the cash needed to distribute redemption proceeds, and they may subsequently recognize gains on such sales. As a result, an investment in Shares redeemed partially or wholly for cash may be less tax-efficient than if the Shares were redeemed through an EFRP transaction which generally will not trigger any tax consequences to Shareholders. Moreover, cash transactions may have to be carried out over several days if the market for any of the Deposit Instruments is relatively illiquid and may involve considerable brokerage fees and taxes. These brokerage fees and taxes, which generally are expected to be higher than if the Basket was created or redeemed through an EFRP transaction, may be passed on to purchasers and redeemers of Baskets in the form of creation and redemption transaction fees. In addition, these factors may result in wider spreads between the bid and the offered prices of the Shares.

 

Authorized Participant Concentration Risk

 

Only an Authorized Participant may engage in creation or redemption transactions directly with the Funds. The Funds may have relationships with a limited number of institutions that act as Authorized Participants. To the extent these institutions exit the business or are unable or unwilling to proceed with creation and/or redemption orders with respect to the Funds and no other Authorized Participant is able to step forward to create or redeem Baskets, Shares of the Funds may trade at a discount to NAV and possibly face trading halts and/or delisting.

 

Guarantees and Indemnifications

 

In the normal course of business, the Funds enter into contracts with third-party service providers that contain a variety of representations and warranties and that provide general indemnifications. Additionally, under the Funds’ organizational documents, the Sponsor, Wilmington Trust, N.A., a national banking association and the trustee of the Trust, and their officers and affiliates are indemnified against certain liabilities arising out of the performance of their duties to the Funds. The Funds’ maximum exposure under these arrangements is unknown, as it involves possible future claims that may or may not be made against the Funds. Based on experience, the Sponsor is of the view that the risk of loss to the Funds in connection with the Funds’ indemnification obligations is remote; however, there can be no assurance that such obligations will not result in material liabilities that adversely affect the Funds.

 

NOTE 9 – RECENTLY ISSUED ACCOUNTING PRONOUNCEMENT

 

In August 2018, the FASB issued Accounting Standards Update 2018-13, Fair Value Measurement (Topic 820). The new guidance includes additions and modifications to disclosures requirements for fair value measurements. For public entities, the amendments are effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. At this time, management is currently evaluating the impact of this new guidance on the financial statements and disclosures.

 

NOTE 10 – SUBSEQUENT EVENTS

 

In preparing these financial statements, management has evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued. Management has determined that there are no material events, except as set forth above that would require disclosure in the Funds’ financial statements through this date.

 

25

 

   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion should be read in conjunction with the financial statements and the notes thereto of Metaurus Equity Component Trust (the “Trust”) included elsewhere in this quarterly report on Form 10-Q.

 

Forward-Looking Information

 

This quarterly report on Form 10-Q, including this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements regarding the plans and objectives of management for future operations. This information may involve known and unknown risks, uncertainties and other factors that may cause the Trust’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe the Trust’s future plans, strategies and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project,” the negative of these words, other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and the Trust cannot assure investors that the projections included in these forward-looking statements will come to pass. the Trust’s actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors.

 

The Trust has based the forward-looking statements included in this quarterly report on Form 10-Q on information available to it on the date of this quarterly report on Form 10-Q, and the Trust assumes no obligation to update any such forward-looking statements. Although the Trust undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, investors are advised to consult any additional disclosures that the Trust may make directly to them or through reports that the Trust in the future files with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

Introduction

 

The Metaurus Equity Component Trust (the “Trust”) is a statutory trust formed under the laws of the State of Delaware in September 2016. The Trust is neither managed like a corporation nor registered as an investment company under the Investment Company Act of 1940 and is not required to register under such act.

 

The U.S. Equity Cumulative Dividends Fund—Series 2027 (the “Dividend Fund”) and the U.S. Equity Ex-Dividend Fund—Series 2027 (the “Ex-Dividend Fund”, and together with the Dividend Fund, the “Funds” and each, a “Fund”) are separate series of the Trust. Each Fund is a commodity pool that will issue shares to shareholders (“Shareholders”) representing fractional undivided beneficial interests in, and ownership of, the net assets of the Fund (“Shares”). The Funds are each passive, unleveraged investment pools.

 

Shares in each Fund are being separately offered. The Funds are term funds that will terminate on or prior to December 31, 2027. Each of the Funds began issuing shares on February 5, 2018, and their units of beneficial interest (“Shares”) represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the New York Stock Exchange Archipelago (a/k/a NYSE Arca). The Trust qualifies as an “emerging growth company” subject to reduced public company reporting requirements under U.S. federal securities laws.

 

On May 11, 2018, the Funds filed a prospectus supplement with the SEC and the NFA, which was accepted and approved by the SEC and NFA on the same day. The supplement provides that the Sponsor is currently voluntarily waiving a portion of its management fee from the ETFs and that this voluntary waiver may be modified or terminated at any time at the option of the Sponsor.

 

On January 31, 2019, the Funds filed a prospectus supplement with the SEC and the NFA, which was accepted and approved by the SEC and NFA on the same day. The supplement provides updated data concerning distributions, performance, and break-even analysis, and updated information concerning the principals of the Sponsor.

 

The Funds filed a post-effective amendment to the registration statement with the SEC on April 11, 2019, and with the NFA on April 12, 2019, which was declared effective by the SEC and accepted by the NFA on April 18, 2019. The registration statement is dated April 19, 2019.

 

Metaurus Advisors LLC (“Metaurus”) is the sponsor, commodity pool operator and commodity trading advisor of each Fund. Metaurus, a limited liability company formed in the State of Delaware on September 15, 2016, serves as the Trust’s Sponsor, commodity pool operator and commodity trading advisor. The Sponsor is exempt from registration as a commodity trading advisor with the CFTC under CFTC Rule 4.14(a)(4), as the Sponsor is registered as a commodity pool operator, and the Sponsor’s commodity trading advice is directed solely to, and for the sole use of, the Funds, pools for which it is so registered. The address of Metaurus is 589 Fifth Avenue, Suite 808, New York, NY 10017. The main business telephone number of Metaurus is (212) 634-4250. The Trust had no investment operations prior to February 5, 2018, other than matters relating to its organization, the registration of each series under the Securities Act of 1933, as amended, and the contribution of $1,000 in each Fund by the Sponsor.

 

The Sponsor is responsible for making operational decisions necessary to maintain the proper number of investment positions to meet the investment objectives of the Funds, monitor the performance results of the Funds’ portfolios and reallocate assets within the portfolios with a view to causing the performance of each Fund’s portfolio to track that of its Underlying Index over each calendar year. Each Fund is designed to terminate operations in December 2027.

 

Each of the Funds generally invests 100% of its assets in U.S Treasury Securities, cash and cash equivalent securities and seeks to gain exposure to certain financial futures whose value is derived from the underlying assets, as a substitute for investing directly in U.S equity securities directly, in order to gain or lose exposure to certain component of their return.

 

26

 

   

More specifically, the Dividend Fund is a passive, unleveraged fund that seeks to track the Solactive U.S. Cumulative Dividends Index - Series 2027 (the “Dividends Index”). The Dividends Index (and the Dividend Fund) seeks to represent the discounted present value of all dividend futures contracts out to and including December 2027. Each annual dividend futures contract represents the total value of all dividends paid on the S&P 500 Index constituent stocks during the contract year (as measured from mid-December to mid-December). The Dividend Fund holds a portfolio of sequentially maturing U.S. Treasury Notes and cash. In order to gain exposure to the annual dividends paid on the S&P 500 Index in each year, the Dividend Fund holds long positions in the series of annual dividend futures contracts that are linked to the amounts of dividends paid on the S&P 500 Index constituent stock in each year during the term of the Dividend Fund. Unlike most futures contracts, dividend futures contracts do not need to be “rolled” periodically but may be held to their annual expiry.

 

The Ex-Dividend Fund is a passive, unleveraged fund that seeks to track the Solactive U.S. Ex-Dividends Index - Series 2027 (the “Ex-Dividends Index”). The Ex-Dividends Index (and the Ex-Dividend Fund) seeks to gain exposure to U.S. equities at a discounted price by holding 100% of its assets in short-term U.S. Treasury securities and cash and gaining exposure to the U.S. equity market by holding long positions in S&P 500 Index futures and short positions in S&P 500 dividend futures contracts. The shot positions in the dividend futures contracts allow the fund to access index exposure at a discount to purchasing shares of the index itself.

 

Each Fund continuously offers and redeems its Shares in blocks of 50,000 Shares (each such block a “Creation Unit”). Only Authorized Participants may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized Participant is an entity that has entered into an Authorized Participant Agreement with one or more of the Funds. Shares of the Funds are offered to Authorized Participants in Creation Units at each Fund’s respective NAV. Authorized Participants may then offer to the public, from time to time, Shares from any Creation Unit they create at a per-Share market price that varies depending on, among other factors, the trading price of the Shares of each Fund on the NYSE Arca, the NAV and the supply of and demand for the Shares at the time of the offer. Shares from the same Creation Unit may be offered at different times and may have different offering prices based upon the above factors. The form of Authorized Participant Agreement and related Authorized Participant Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation Unit. Authorized Participants do not receive from any Fund, the Sponsor, or any of their affiliates, any underwriting fees or compensation in connection with their sale of Shares to the public.

 

Liquidity and Capital Resources

 

In order to maintain margin on futures positions held by the Funds, a portion of the NAV of each Fund is held in cash and/or U.S. Treasury securities at Morgan Stanley, the Funds’ Futures Commission Merchant, and, in the case of the Dividend Fund, to fund its monthly distributions. The Funds also maintain cash positions to fund certain fees and expenses of the Funds. The percentage that U.S. Treasury bills and other short-term cash positions held by the Funds can be expected to vary from period to period as the market values of the underlying futures contracts change.

 

The Sponsor is not aware of any other demands, commitments, events or uncertainties that are reasonably likely to result in material changes to the liquidity needs of either Fund. As of May 2018, the Sponsor has agreed to assume or waive a significant portion of the fees and expenses of the Funds. The assumption or waiver of these fees and expenses is voluntary by the Sponsor and may be reduced or eliminated at any time by the Sponsor.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

See Note 8 – RISK, above.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

The duly authorized officers of the Sponsor, performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, have evaluated the effectiveness of the Trust’s disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust were effective as of the end of the period covered by this report. Such disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the Securities Exchange Act of 1934, as amended, are recorded, processed, summarized and reported, within the time period specified in the applicable rules and forms, and that such information is accumulated and communicated to the duly authorized officers of the Sponsor performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, to allow timely decisions regarding required disclosure.

 

Internal Control over Financial Reporting

 

There has been no change in the internal control over financial reporting that occurred during the fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.

 

27

 

   

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, the Funds may receive subpoenas or other requests for information from various U.S. federal, state governmental and domestic and international regulatory authorities in connection with certain industry-wide or other investigations or proceedings. It is the Funds’ general policy to cooperate fully with such inquiries. The Funds may also be named as defendants in legal actions, including arbitrations and other litigation arising in connection with their activities, any of which potentially could harm the investment returns of the Fund or result in it being liable for any resulting damages.

 

The Sponsor, after consultation with legal counsel, currently does not anticipate that the aggregate liability arising out of regulatory matters or lawsuits, if any, will have a material effect on either Fund’s results of operations, financial position, or cash flows. However, there is no assurance as to whether any such pending or threatened matters, if any, will have a material effect on a Fund’s results of operations, financial position or cash flows in any future reporting period. Due to uncertainties surrounding the outcome of these matters, if any, the Funds cannot reasonably estimate the possible loss or range of loss that may arise from these matters, if any.

 

Item 1A. Risk Factors.

 

Shareholders should carefully consider the factors discussed beginning Page 12 “Risk Factors” in our prospectus dated April 19, 2019, which could materially affect our business, financial condition or future results. The risks described in the prospectus are not the only risks facing the Trust. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

a) None.

 

b) Not applicable.

 

c) For the three months ended March 31, 2019: 2 Baskets were redeemed

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

Exhibit
Number
  Description
     
31.1*   Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

*Filed herewith.

 

28

 

   

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Metaurus Advisors LLC
  Sponsor of the Metaurus Equity Component Trust
  (Registrant)
     
Date:  May 15, 2019 By: /s/ Jamie Greenwald
    Jamie Greenwald
    Co-Chief Executive Officer
     
Date:  May 15, 2019 By: /s/ Donald M. Callahan
    Donald M. Callahan
    Chief Financial Officer

 

*The Registrant is a trust and the persons are signing in their capacities as officers of Metaurus Advisors LLC, the Sponsor of the Registrant.

 

29

 

   

Exhibit Index

 

Exhibit
Number
  Description
     
31.1*   Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

*Filed herewith.

 

 

30